Beckman Coulter 472137 Hemolyzing Reagent HbA1c Diluent

Description

Product Description: Beckman Coulter 472137 Hemolyzing Reagent HbA1c Diluent

Diluent for HbA1c sample preparation.
For use as an A1c Level 1 calibrator for HbA1c and HbA1c2.
Also known as “SCD, HEMOLYZING SOLN 1000TEST CX/L”.
Compatible with AU 2000 Series Chemistry Analyzers
Compatible with AU 400 Series Chemistry Analyzers
Compatible with AU 600 Series Chemistry Analyzers

Intended Use: Beckman Coulter 472137 Hemolyzing Reagent HbA1c Diluent

The Beckman Coulter 472137 HbA1c reagent (Hemoglobin A1c) Hemolyzing Reagent , when used in conjunction with Beckman Coulter Systems, HbA1c Calibrators, and SYNCHRON and AU Hemolyzing Reagent, is intended for the quantitative determination of hemoglobin A1c concentration in human whole blood.
The absolute HbA1c and Total Hemoglobin (THb) values generated as part of the HbA1c assay are intended for use in the calculation of the HbA1c/Total Hemoglobin ratio, and must not be used individually for diagnostic purposes.

About Beckman Coulter 472137 Hemolyzing Reagent HbA1c Diluent

Measurement of hemoglobin A1c is accepted as a method to measure long-term glucose control in patients with diabetes mellitus (a chronic disorder associated with disturbances in carbohydrate, fat, and protein metabolism and characterized by hyperglycemia). Determination of HbA1c provides an important tool for monitoring the efficiency of dietary control and therapy during the treatment of diabetes mellitus. Long-term treatment of the disease emphasizes control of blood glucose levels in preventing the acute complications of ketosis and hyperglycemia. In addition, long-term complications such as retinopathy, neuropathy, and cardiovascular disease can be minimized if blood glucose levels are effectively controlled.

The process of conversion from hemoglobin A to hemoglobin A1c depends on the blood glucose concentration. Since the average life of a red blood cell is 120 days, measurement of hemoglobin A1c can reflect the mean daily blood glucose concentration over the preceding two to three months and provides a much better indication of glycemic control than blood or urinary glucose determinations.